A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02214654

Recruitment Status : Unknown

Verified April 2014 by Xiaofei Wang, Tianjin First Central Hospital.
Recruitment status was: Not yet recruiting

First Posted : August 12, 2014

Last Update Posted : August 12, 2014

Sponsor:

Collaborator:

AstraZeneca

Information provided by (Responsible Party):

Xiaofei Wang, Tianjin First Central Hospital

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 2015
Estimated Study Completion Date :	June 2015

To Top